---
figid: PMC4113147__1476-4598-13-96-8
figtitle: Schematic overview presenting the role of RasGRP3 in mediating the Ras signaling
  pathways in breast carcinoma cells
organisms:
- Bos taurus
- Armoracia rusticana
- Canis lupus familiaris
- Schizosaccharomyces pombe
- Homo sapiens
- Mus musculus
pmcid: PMC4113147
filename: 1476-4598-13-96-8.jpg
figlink: /pmc/articles/PMC4113147/figure/F8/
number: F8
caption: 'A schematic overview presenting the role of RasGRP3 in mediating the Ras
  signaling pathways in breast carcinoma cells. The signaling of growth factors (such
  as IGF-I and EGF) through downstream signaling molecules to ERα is mediated by RasGRP3.
  Inhibition of the Ras signaling pathway at the RasGRP3 level bears the potential
  to suppress downstream activation and ligand independent activation of ERα resulting
  in a decreased proliferation and chemotherapeutic resistance. Abbreviations: IGFR:
  insulin-like growth factor-I receptor; EGFR: epidermal growth factor receptor; HER-2:
  Human Epidermal Growth Factor Receptor 2; IGF-I: insulin-like growth factor-I; EGF:
  epidermal growth factor; PLC: phospholipase C; DAG: diacylglycerol; C1: C1 domain;
  RasGRP3: Ras guanil nucleotid releasing protein 3; GTP: guanosine triphosphate;
  Ras: H-Ras or R-Ras; Raf: raf kinase; MEK and ERK 1/2: mitogen-activated protein
  kinases; PI3K: phosphoinositide 3-kinase; Akt: Akt kinase; ER: estrogen receptor
  alpha; P: phosphate group.'
papertitle: Function of RasGRP3 in the formation and progression of human breast cancer.
reftext: Zsuzsanna Nagy, et al. Mol Cancer. 2014;13:96-96.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9466656
figid_alias: PMC4113147__F8
figtype: Figure
organisms_ner:
- Mus musculus
redirect_from: /figures/PMC4113147__F8
ndex: df488cbc-defc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4113147__1476-4598-13-96-8.html
  '@type': Dataset
  description: 'A schematic overview presenting the role of RasGRP3 in mediating the
    Ras signaling pathways in breast carcinoma cells. The signaling of growth factors
    (such as IGF-I and EGF) through downstream signaling molecules to ERα is mediated
    by RasGRP3. Inhibition of the Ras signaling pathway at the RasGRP3 level bears
    the potential to suppress downstream activation and ligand independent activation
    of ERα resulting in a decreased proliferation and chemotherapeutic resistance.
    Abbreviations: IGFR: insulin-like growth factor-I receptor; EGFR: epidermal growth
    factor receptor; HER-2: Human Epidermal Growth Factor Receptor 2; IGF-I: insulin-like
    growth factor-I; EGF: epidermal growth factor; PLC: phospholipase C; DAG: diacylglycerol;
    C1: C1 domain; RasGRP3: Ras guanil nucleotid releasing protein 3; GTP: guanosine
    triphosphate; Ras: H-Ras or R-Ras; Raf: raf kinase; MEK and ERK 1/2: mitogen-activated
    protein kinases; PI3K: phosphoinositide 3-kinase; Akt: Akt kinase; ER: estrogen
    receptor alpha; P: phosphate group.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egf
  - Rasgrp3
  - ci
  - Erbb2
  - Hspg2
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Pik3r1
  - Mdk
  - Akt1
  - Ephb2
  - Mapk1
  - tamoxifen
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
